Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2441–2460 of 17,529 recalls

February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Pirfenidone Tablets 267 mg 90-count bottle x3/Carton

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: rOPINIRole Tablets USP 0.25 mg*

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: BusPIRone Hydrochloride Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Aripiprazole Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Glimepiride Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Clopidogrel Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Tadalafil Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Glimepiride Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Glycopyrrolate Injection

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Pravastatin Sodium Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Doxazosin Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Doxazosin Tablets USP 1 mg

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Rosuvastatin Tablets

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Phenylephrine Hydrochloride Injection

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: rOPINIRole Tablets USP 2 mg*

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: BusPIRone Hydrochloride Tablets USP

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: rOPINIRole Tablets USP 5 mg* 100-count bottle

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: rOPINIRole Tablets USP 3 mg*

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: BusPIRone Hydrochloride Tablets USP 7.5 mg

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2023· Accord Healthcare, Inc.

Recalled Item: Pirfenidone Tablets 801 mg

The Issue: CGMP Deviations: recalling drug products following an FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund